| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Director | Stock Options | 146,974 | $382,132 | $2.60 | 27 Jun 2024 | Direct |
| Cardiff Oncology, Inc. | Director | Stock Options | 158,681 | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 19:40 |
| CRDF | Cardiff Oncology, Inc. | 27 Jun 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 16:09 |
| CRDF | Cardiff Oncology, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 17:05 |
| CRDF | Cardiff Oncology, Inc. | 19 Sep 2022 | 1 | +$24,525 | 4 | Director | 20 Sep 2022, 18:08 |
| CRDF | Cardiff Oncology, Inc. | 05 Jul 2022 | 2 | $0 | 4 | Director | 06 Jul 2022, 16:10 |
| CRDF | Cardiff Oncology, Inc. | 09 Mar 2022 | 1 | $0 | 4 | Director | 10 Mar 2022, 17:43 |
| OABI | Avista Public Acquisition Corp. II | 09 Aug 2021 | 0 | $0 | 3 | Director | 09 Aug 2021, 21:59 |
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:14 |